ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costabel, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costabel, U
Eur Respir J 1988; 1: 5-9
Copyright © ERS Journals Ltd 1988


Original Articles

The alveolitis of hypersensitivity pneumonitis

U Costabel

In the pathogenesis of hypersensitivity pneumonitis (HP) several immune mechanisms are involved. The initial phase, 4-48 h after antigen inhalation, appears to be immune complex mediated and is characterized by an early increase in bronchoalveolar lavage (BAL) neutrophils and the histopathologic features of oedema, neutrophil infiltration of the alveolar wall, and vasculitis. After 12 h to several days, the immune response possibly shifts to a cell-mediated reaction, and the alveolitis consists of cytotoxic effector cells as well as suppressor cells which may be required to modulate the B cell response of antibody production by plasma cells. In this phase, lymphocytes of the OKT8 positive phenotype, natural killer cells, and occasionally a few plasma cells are increased in BAL fluid. The characteristic histopathologic finding is a mononuclear infiltrate consisting of lymphocytes, plasma cells, and foamy histiocytes. After weeks to months, a delayed type hypersensitivity reaction may lead to a slight predominance of OKT4 positive cells in BAL fluid and to granuloma formation. Finally, after months to years, repeated immune-mediated injury to the alveolar wall with release of proteolytic enzymes and fibroblast growth factors may result in pulmonary fibrosis and end stage lung with concomitant increase in BAL neutrophils as in other fibrotic diseases.


This article has been cited by other articles:


Home page
ChestHome page
J. Lee, C. Lee, and C. H. Kim
Uncontrolled Occupational Exposure to 1,1-Dichloro-1-Fluoroethane (HCFC-141b) Is Associated With Acute Pulmonary Toxicity
Chest, January 1, 2009; 135(1): 149 - 155.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Korosec, K. Osolnik, I. Kern, M. Silar, K. Mohorcic, and M. Kosnik
Expansion of Pulmonary CD8+CD56+ Natural Killer T-Cells in Hypersensitivity Pneumonitis
Chest, October 1, 2007; 132(4): 1291 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Q. Ye, B. Chen, Z. Tong, S. Nakamura, R. Sarria, U. Costabel, and J. Guzman
Thalidomide reduces IL-18, IL-8 and TNF-{alpha} release from alveolar macrophages in interstitial lung disease
Eur. Respir. J., October 1, 2006; 28(4): 824 - 831.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Ratjen, U. Costabel, M. Griese, and K. Paul
Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis
Eur. Respir. J., January 1, 2003; 21(1): 144 - 148.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Y. Yamamoto, S. Osanai, S. Fujiuchi, K. Yamazaki, H. Nakano, Y. Ohsaki, and K. Kikuchi
Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii
Eur. Respir. J., November 1, 2002; 20(5): 1351 - 1353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. BEHR, B. DEGENKOLB, T. BEINERT, F. KROMBACH, and C. VOGELMEIER
Pulmonary Glutathione Levels in Acute Episodes of Farmer's Lung
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1968 - 1971.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. MIYAGAWA, S. HAMAGAMI, and N. TANIGAWA
Cryptococcus albidus-induced Summer-type Hypersensitivity Pneumonitis
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 961 - 966.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. J. Harbeck

Clin. Vaccine Immunol., May 1, 1998; 5(3): 271 - 277.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the European Respiratory Society.